000126113 001__ 126113
000126113 005__ 20190112084000.0
000126113 0247_ $$2doi$$a10.1007/s00508-006-0736-5
000126113 02470 $$2DAR$$a10525
000126113 02470 $$a000246523400003$$2ISI
000126113 037__ $$aARTICLE
000126113 245__ $$aViral vectors as a tool to model and treat Parkinson's disease
000126113 269__ $$a2006
000126113 260__ $$c2006
000126113 336__ $$aJournal Articles
000126113 500__ $$aSchool of Life Sciences, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland.
000126113 6531_ $$aAnimals
000126113 6531_ $$aBrain/metabolism
000126113 6531_ $$aCell Death/genetics
000126113 6531_ $$aGene Therapy/*methods
000126113 6531_ $$a*Gene Transfer Techniques
000126113 6531_ $$aGenetic Vectors/*genetics
000126113 6531_ $$aHumans
000126113 6531_ $$aLentivirus/genetics
000126113 6531_ $$aLewy Bodies/genetics/pathology
000126113 6531_ $$aParkinson Disease/genetics/pathology/*therapy
000126113 6531_ $$aUbiquitin-Protein Ligases/genetics
000126113 6531_ $$aalpha-Synuclein/genetics
000126113 700__ $$0240445$$g150317$$aBensadoun, J.C.
000126113 700__ $$0240206$$g104359$$aAebischer, P.
000126113 773__ $$j118$$tWien Klin Wochenschr$$k19-20$$q568-70
000126113 909C0 $$xU10457$$0252067$$pLEN
000126113 909CO $$pSV$$particle$$ooai:infoscience.tind.io:126113
000126113 937__ $$aLEN-ARTICLE-2006-011
000126113 973__ $$rREVIEWED$$sPUBLISHED$$aEPFL
000126113 980__ $$aARTICLE